{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:11:23Z","timestamp":1783987883845,"version":"3.55.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (FCT), I.P., under the R&D unit Global Health and Tropical Medicine  and the Associated Laboratory in Translation and Innovation Towards Global Health REAL .","award":["(UID\/04413\/2025) & (LA\/P\/0117\/2020)"],"award-info":[{"award-number":["(UID\/04413\/2025) & (LA\/P\/0117\/2020)"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (FCT), I.P., under the R&D unit Global Health and Tropical Medicine  and the Associated Laboratory in Translation and Innovation Towards Global Health REAL","award":["(UID\/04413\/2025) & (LA\/P\/0117\/2020)."],"award-info":[{"award-number":["(UID\/04413\/2025) & (LA\/P\/0117\/2020)."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-026-05939-4","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T08:57:21Z","timestamp":1779267441000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasmodium falciparum antimalarial resistance in Angola: a systematic review"],"prefix":"10.1186","volume":"25","author":[{"given":"Daniela","family":"Matias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Micolo","family":"C\u00e2ndido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Morais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lina","family":"Antunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Guler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1tima","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ac\u00e1cio","family":"Salamandane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"5939_CR1","unstructured":"Drame A Integrated malaria control in sub-Saharan Africa: The emerging central role of RTS, S vaccination: A comparative review 2024."},{"key":"5939_CR2","unstructured":"World Health Organization. Angola launches \u201cZero Malaria Starts With Me\u201d campaign 2023 [cited 2025 Oct 31]. Available from: https:\/\/www.afro.who.int\/countries\/angola\/news\/angola-launches-zero-malaria-starts-me-campaign"},{"issue":"1","key":"5939_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-017-1712-4","volume":"16","author":"MM Plucinski","year":"2017","unstructured":"Plucinski MM, Dimbu PR, Macaia AP, Ferreira CM, Samutondo C, Quivinja J, et al. Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015. Malar J. 2017;16(1):1\u201310.","journal-title":"Malar J"},{"issue":"1","key":"5939_CR4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12936-018-2290-9","volume":"17","author":"E Davlantes","year":"2018","unstructured":"Davlantes E, Dimbu PR, Ferreira CM, Florinda Joao M, Pode D, F\u00e9lix J, et al. Efficacy and safety of artemether\u2013lumefantrine, artesunate\u2013amodiaquine, and dihydroartemisinin\u2013piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017. Malaria j. 2018;17(1):144.","journal-title":"Malaria j"},{"issue":"10","key":"5939_CR5","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","volume":"26","author":"A Uwimana","year":"2020","unstructured":"Uwimana A, Legrand E, Stokes BH, Ndikumana JL, Warsame M, Umulisa N, et al. Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nature med. 2020;26(10):1602\u20138.","journal-title":"Nature med"},{"issue":"13","key":"5939_CR6","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","volume":"385","author":"B Balikagala","year":"2021","unstructured":"Balikagala B, Fukuda N, Ikeda M, Katuro OT, Tachibana SI, Yamauchi M, et al. Evidence of artemisinin-resistant malaria in Africa. New England J Med. 2021;385(13):1163\u201371.","journal-title":"New England J Med."},{"issue":"1","key":"5939_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12879-025-10462-z","volume":"25","author":"V Osoti","year":"2025","unstructured":"Osoti V, Wamae K, Ndwiga L, Gichuki PM, Okoyo C, Kepha S, et al. Detection of low frequency artemisinin resistance mutations, C469Y, P553L and A675V, and fixed antifolate resistance mutations in asymptomatic primary school children in Kenya. BMC Infect Dis. 2025;25(1):73.","journal-title":"BMC Infect Dis"},{"key":"5939_CR8","unstructured":"PMI, United States Agency for International Development (USAID). U.S. President\u2019s Malaria Initiative - Angola - Malaria Operational Plan FY 2022. Washington (DC); 2021. Available from: https:\/\/reliefweb.int\/report\/angola\/presidents-malaria-initiative-angola-malaria-operational-plan-fy-2022"},{"issue":"1","key":"5939_CR9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1128\/AAC.04181-14","volume":"59","author":"MM Plucinski","year":"2015","unstructured":"Plucinski MM, Talundzic E, Morton L, Dimbu PR, Macaia AP, Fortes F, et al. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and U\u00edge provinces. Angola Antimicrob Agents Chemother. 2015;59(1):437\u201343.","journal-title":"Angola Antimicrob Agents Chemother"},{"issue":"2","key":"5939_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.01949-20","volume":"65","author":"PR Dimbu","year":"2021","unstructured":"Dimbu PR, Horth R, C\u00e2ndido AL, Ferreira CM, Caquece F, Garcia LE, et al. Continued Low Efficacy of Artemether-Lumefantrine in Angola in 2019. Antimicrob agents chemother. 2021;65(2):10\u2013128.","journal-title":"Antimicrob agents chemother"},{"key":"5939_CR11","unstructured":"Assembleia Nacional de Angola. Lei n.o 14\/24, de 5 de Setembro \u2013 Lei da Divis\u00e3o Pol\u00edtico-Administrativa. 2024. Available from: https:\/\/mpla.ao\/wp-content\/uploads\/2024\/09\/Lei14.24de5deSetembro.pdf"},{"issue":"9","key":"5939_CR12","doi-asserted-by":"publisher","first-page":"e591","DOI":"10.1016\/S1473-3099(24)00141-5","volume":"24","author":"PJ Rosenthal","year":"2024","unstructured":"Rosenthal PJ, Asua V, Bailey JA, Conrad MD, Ishengoma DS, Kamya MR, et al. The emergence of artemisinin partial resistance in Africa: how do we respond? Lancet Infect Dis. 2024;24(9):e591-600.","journal-title":"Lancet Infect Dis"},{"key":"5939_CR13","doi-asserted-by":"publisher","unstructured":"Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Naud\u00e9 B, Deitsch KW, Su XZ, Wootton JC. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Molecular cell 2000 https:\/\/doi.org\/10.1016\/s1097-2765(05)00077-8.","DOI":"10.1016\/s1097-2765(05)00077-8"},{"issue":"1","key":"5939_CR14","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/1475-2875-9-374","volume":"9","author":"JM Sa","year":"2010","unstructured":"Sa JM, Twu O. Protecting the malaria drug arsenal: halting the rise and spread of amodiaquine resistance by monitoring the PfCRT SVMNT type. Malaria j. 2010;9(1):374.","journal-title":"Malaria j"},{"issue":"11","key":"5939_CR15","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.pt.2012.08.002","volume":"28","author":"A Ecker","year":"2012","unstructured":"Ecker A, Lehane AM, Clain J, Fidock DA. PfCRT and its role in antimalarial drug resistance. Trends parasitology. 2012;28(11):504\u201314.","journal-title":"Trends parasitology."},{"issue":"3","key":"5939_CR16","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.actatropica.2011.08.013","volume":"120","author":"OA Folarin","year":"2011","unstructured":"Folarin OA, Bustamante C, Gbotosho GO, Sowunmi A, Zalis MG, Oduola AM, et al. In vitro amodiaquine resistance and its association with mutations in pfcrt and pfmdr1 genes of Plasmodium falciparum isolates from Nigeria. Acta Trop. 2011;120(3):224\u201330.","journal-title":"Acta Trop"},{"issue":"5","key":"5939_CR17","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1086\/596738","volume":"199","author":"C Sisowath","year":"2009","unstructured":"Sisowath C, Petersen I, Veiga MI, M\u00e5rtensson A, Premji Z, Bj\u00f6rkman A, et al. In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 Allele after treatment with artemether-lumefantrine in Africa. J Infect Dis. 2009;199(5):750\u20137.","journal-title":"J Infect Dis"},{"issue":"1","key":"5939_CR18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12936-020-03281-x","volume":"19","author":"FT Foguim","year":"2020","unstructured":"Foguim FT, Bogreau H, Gendrot M, Mosnier J, Fonta I, Benoit N, et al. Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolates. Malaria j. 2020;19(1):201.","journal-title":"Malaria j"},{"issue":"4","key":"5939_CR19","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/infdis\/jix334","volume":"216","author":"S Agrawal","year":"2017","unstructured":"Agrawal S, Moser KA, Morton L, Cummings MP, Parihar A, Dwivedi A, et al. Association of a novel mutation in the Plasmodium falciparum chloroquine resistance transporter with decreased piperaquine sensitivity. J Infect Dis. 2017;216(4):468\u201376.","journal-title":"J Infect Dis"},{"issue":"1","key":"5939_CR20","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1038\/s41467-018-05652-0","volume":"9","author":"LS Ross","year":"2018","unstructured":"Ross LS, Dhingra SK, Mok S, Yeo T, Wicht KJ, K\u00fcmpornsin K, et al. Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine. Nat Commun. 2018;9(1):3314.","journal-title":"Nat Commun"},{"issue":"1","key":"5939_CR21","doi-asserted-by":"publisher","first-page":"13419","DOI":"10.1038\/s41598-021-92735-6","volume":"11","author":"N Boonyalai","year":"2021","unstructured":"Boonyalai N, Thamnurak C, Sai-Ngam P, Ta-Aksorn W, Arsanok M, Uthaimongkol N, et al. Plasmodium falciparum phenotypic and genotypic resistance profile during the emergence of Piperaquine resistance in Northeastern Thailand. Sci Rep. 2021;11(1):13419.","journal-title":"Sci Rep"},{"issue":"1","key":"5939_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1124\/pr.57.1.4","volume":"57","author":"A Gregson","year":"2005","unstructured":"Gregson A, Plowe CV. Mechanisms of resistance of malaria parasites to antifolates. Pharmacol Rev. 2005;57(1):117\u201345.","journal-title":"Pharmacol Rev"},{"issue":"23","key":"5939_CR23","doi-asserted-by":"publisher","first-page":"9114","DOI":"10.1073\/pnas.85.23.9114","volume":"85","author":"DS Peterson","year":"1988","unstructured":"Peterson DS, Walliker D, Wellems TE. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Nat Acad Sci. 1988;85(23):9114\u20138.","journal-title":"Proc Nat Acad Sci."},{"issue":"1","key":"5939_CR24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/1475-2875-6-148","volume":"6","author":"S Zakeri","year":"2007","unstructured":"Zakeri S, Afsharpad M, Raeisi A, Djadid ND. Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran. Malar J. 2007;6(1):148.","journal-title":"Malar J"},{"issue":"2","key":"5939_CR25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0166-6851(97)00114-X","volume":"89","author":"P Wang","year":"1997","unstructured":"Wang P, Lee CS, Bayoumi R, Djimde A, Doumbo O, Swedberg G, et al. Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. Mol biochem parasit. 1997;89(2):161\u201377.","journal-title":"Mol biochem parasit"},{"issue":"4","key":"5939_CR26","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00436-005-1424-5","volume":"97","author":"PJ Berzosa","year":"2005","unstructured":"Berzosa PJ, Puente S, Benito A. Malaria cure with sulphadoxine\/pyrimethamine combination in 12 semi-immune adults from West-Central Africa with high rates of point mutations in Plasmodium falciparum dhfr and dhps genes. Parasitol Res. 2005;97(4):287\u20139.","journal-title":"Parasitol Res"},{"issue":"1","key":"5939_CR27","doi-asserted-by":"publisher","first-page":"13222","DOI":"10.1038\/s41598-025-98035-7","volume":"15","author":"NF White","year":"2025","unstructured":"White NF, Whitton G, Wasakul V, Amenga-Etego L, Dara A, Andrianaranjaka V, et al. Disparate co-evolution and prevalence of sulfadoxine and pyrimethamine resistance alleles and haplotypes at dhfr and dhps genes across Africa. Sci Rep. 2025;15(1):13222.","journal-title":"Sci Rep"},{"issue":"3","key":"5939_CR28","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1086\/338566","volume":"185","author":"JG Kublin","year":"2002","unstructured":"Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, et al. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis. 2002;185(3):380\u20138.","journal-title":"J Infect Dis"},{"issue":"1","key":"5939_CR29","doi-asserted-by":"publisher","first-page":"7389","DOI":"10.1038\/s41598-017-06708-9","volume":"7","author":"LC Okell","year":"2017","unstructured":"Okell LC, Griffin JT, Roper C. Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa. Sci Rep. 2017;7(1):7389.","journal-title":"Sci Rep"},{"issue":"4","key":"5939_CR30","first-page":"e00109","volume":"37","author":"NJ White","year":"2024","unstructured":"White NJ, Chotivanich K. Artemisinin-resistant malaria. Clin Microbio Rev. 2024;37(4):e00109-e124.","journal-title":"Clin Microbio Rev."},{"issue":"10","key":"5939_CR31","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1093\/infdis\/jiv249","volume":"212","author":"F Huang","year":"2015","unstructured":"Huang F, Takala-Harrison S, Jacob CG, Liu H, Sun X, Yang H, et al. A Single mutation in K13 predominates in Southern China and is associated with delayed clearance of Plasmodium falciparum following artemisinin treatment. J Infect Dis. 2015;212(10):1629\u201335.","journal-title":"J Infect Dis"},{"issue":"8","key":"5939_CR32","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3201\/eid2208.160004","volume":"22","author":"M Boull\u00e9","year":"2016","unstructured":"Boull\u00e9 M, Witkowski B, Duru V, Sriprawat K, Nair SK, McDew-White M, et al. Artemisinin-resistant Plasmodium falciparum K13 mutant alleles, Thailand-Myanmar border. Emerg Infect Dis. 2016;22(8):1503.","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"5939_CR33","doi-asserted-by":"publisher","first-page":"e01659","DOI":"10.1128\/aac.01659-23","volume":"68","author":"P Awor","year":"2024","unstructured":"Awor P, Copp\u00e9e R, Khim N, Rondepierre L, Roesch C, Khean C, et al. Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda. Antimicrob Agent Chemother. 2024;68(8):e01659-e1723.","journal-title":"Antimicrob Agent Chemother."},{"issue":"7481","key":"5939_CR34","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505(7481):50\u20135.","journal-title":"Nature"},{"issue":"4","key":"5939_CR35","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1016\/S1473-3099(20)30493-X","volume":"21","author":"NK Kayiba","year":"2021","unstructured":"Kayiba NK, Yobi DM, Tshibangu-Kabamba E, Tuan VP, Yamaoka Y, Devleesschauwer B, et al. Spatial and molecular mapping of Pfkelch13 gene polymorphism in Africa in the era of emerging Plasmodium falciparum resistance to artemisinin: a systematic review. Lancet Infect Dis. 2021;21(4):e82-92.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"5939_CR36","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4269\/ajtmh.15-0477","volume":"94","author":"AG Bayih","year":"2016","unstructured":"Bayih AG, Getnet G, Alemu A, Getie S, Mohon AN, Pillai DR. A unique Plasmodium falciparum Kelch 13 gene mutation in northwest Ethiopia. American j Trop Med Hyg. 2016;94(1):132.","journal-title":"American j Trop Med Hyg."},{"key":"5939_CR37","doi-asserted-by":"crossref","unstructured":"Alemayehu AA, Castaneda-Mogollon D, Tesfa H, Getie S, Mohon AN, Balasingam N, et al. Expansion of the Plasmodium falciparum Kelch 13 R622I mutation in Northwest Ethiopia. 2021 [cited 2025 Oct 31]. Available from: https:\/\/www.researchsquare.com\/article\/rs-171038\/v1","DOI":"10.21203\/rs.3.rs-171038\/v1"},{"issue":"1","key":"5939_CR38","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1038\/ncomms11553","volume":"7","author":"MI Veiga","year":"2016","unstructured":"Veiga MI, Dhingra SK, Henrich PP, Straimer J, Gn\u00e4dig N, Uhlemann AC, et al. Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies. Nat Commun. 2016;7(1):11553.","journal-title":"Nat Commun"},{"issue":"1","key":"5939_CR39","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1146\/annurev-micro-020518-115546","volume":"74","author":"KJ Wicht","year":"2020","unstructured":"Wicht KJ, Mok S, Fidock DA. Molecular Mechanisms of Drug Resistance in Plasmodium falciparum Malaria. Annual Rev Microbio. 2020;74(1):431\u201354.","journal-title":"Annual Rev Microbio"},{"issue":"1","key":"5939_CR40","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s12936-016-1474-4","volume":"15","author":"B Huang","year":"2016","unstructured":"Huang B, Wang Q, Deng C, Wang J, Yang T, Huang S, et al. Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine. Malar J. 2016;15(1):414.","journal-title":"Malar J"},{"issue":"11","key":"5939_CR41","doi-asserted-by":"publisher","first-page":"6057","DOI":"10.3390\/ijms22116057","volume":"22","author":"H Maiga","year":"2021","unstructured":"Maiga H, Grivoyannis A, Sagara I, Traore K, Traore OB, Tolo Y, et al. Selection of pfcrt K76 and pfmdr1 N86 Coding Alleles after Uncomplicated Malaria Treatment by Artemether-Lumefantrine in Mali. Int J Mol Sci. 2021;22(11):6057.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"5939_CR42","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/infdis\/jir486","volume":"204","author":"FN Baliraine","year":"2011","unstructured":"Baliraine FN, Rosenthal PJ. Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum Malaria with artemether-lumefantrine in Uganda. J Infect Dis. 2011;204(7):1120\u20134.","journal-title":"J Infect Dis"},{"issue":"3","key":"5939_CR43","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/infdis\/jiu141","volume":"210","author":"MD Conrad","year":"2014","unstructured":"Conrad MD, LeClair N, Arinaitwe E, Wanzira H, Kakuru A, Bigira V, et al. Comparative impacts over 5 years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan children. J Infect Dis. 2014;210(3):344\u201353.","journal-title":"J Infect Dis"},{"issue":"6","key":"5939_CR44","doi-asserted-by":"publisher","first-page":"e1119","DOI":"10.1093\/infdis\/jiaf155","volume":"231","author":"C Fan\u00e7ony","year":"2025","unstructured":"Fan\u00e7ony C, Fortes-Gabriel E, Zage F, Alexiou E, Broumou I, Pernaute-Lau L, et al. Artemether-Lumefantrine treatment selects Plasmodium falciparum multidrug resistance 1 (pfmdr1) increased copy number among African malaria infections. J Infect Dis. 2025;231(6):e1119\u201328.","journal-title":"J Infect Dis"},{"key":"5939_CR45","doi-asserted-by":"publisher","unstructured":"Kubota R, Ishino T, Iwanaga S, Shinzawa N. Evaluation of the Effect of Gene Duplication by Genome Editing on Drug Resistance in Plasmodium falciparum. Front Cell Infect Microbiol [Internet]. 2022 Jul 5;12. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fcimb.2022.915656\/full","DOI":"10.3389\/fcimb.2022.915656\/full"},{"issue":"9432","key":"5939_CR46","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","volume":"364","author":"RN Price","year":"2004","unstructured":"Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet. 2004;364(9432):438\u201347.","journal-title":"Lancet"},{"issue":"2","key":"5939_CR47","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S1473-3099(16)30409-1","volume":"17","author":"R Amato","year":"2017","unstructured":"Amato R, Lim P, Miotto O, Amaratunga C, Dek D, Pearson RD, et al. Genetic markers associated with dihydroartemisinin\u2013piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype\u2013phenotype association study. Lancet Infect Dis. 2017;17(2):164\u201373.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"5939_CR48","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1128\/AAC.01793-10","volume":"55","author":"RT Eastman","year":"2011","unstructured":"Eastman RT, Dharia NV, Winzeler EA, Fidock DA. Piperaquine resistance is associated with a copy number variation on chromosome 5 in drug-pressured Plasmodium falciparum parasites. Antimicro Agent Chemother. 2011;55(8):3908\u201316.","journal-title":"Antimicro Agent Chemother."},{"issue":"1","key":"5939_CR49","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/s41467-018-04104-z","volume":"9","author":"S Bopp","year":"2018","unstructured":"Bopp S, Magistrado P, Wong W, Schaffner SF, Mukherjee A, Lim P, et al. Plasmepsin II\u2013III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum. Nat Commun. 2018;9(1):1769.","journal-title":"Nat Commun"},{"issue":"7","key":"5939_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012779","volume":"21","author":"B Walsh","year":"2025","unstructured":"Walsh B, Summers RL, Rangel GW, Hagenah LM, Mok S, Llin\u00e1s M, et al. The plasmepsin-piperaquine paradox persists in Plasmodium falciparum. PLoS Pathog. 2025;21(7):e1012779.","journal-title":"PLoS Pathog"},{"key":"5939_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-10-22","volume":"10","author":"F Fortes","year":"2011","unstructured":"Fortes F, Dimbu R, Figueiredo P, Neto Z, Do Ros\u00e1rio VE, Lopes D. Evaluation of prevalence\u2019s of pfdhfr and pfdhps mutations in Angola. Malar Journal. 2011;10:1\u20137.","journal-title":"Malar Journal"},{"issue":"1","key":"5939_CR52","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/1475-2875-8-275","volume":"8","author":"AK Rowe","year":"2009","unstructured":"Rowe AK, de Le\u00f3n GF, Mihigo J, Santelli AC, Miller NP, Van-D\u00fanem P. Quality of malaria case management at outpatient health facilities in Angola. Malar J. 2009;8(1):275.","journal-title":"Malar J"},{"key":"5939_CR53","first-page":"372","volume":"2021","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. statement: An updated guideline for reporting systematic reviews. BMJ. 2020;2021:372.","journal-title":"BMJ"},{"key":"5939_CR54","doi-asserted-by":"crossref","unstructured":"Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews 2021 Mar 29;372.","DOI":"10.1136\/bmj.n160"},{"key":"5939_CR55","doi-asserted-by":"crossref","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. bmj. 2016 Oct 12;355.","DOI":"10.1136\/bmj.i4919"},{"issue":"1","key":"5939_CR56","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12936-021-03713-2","volume":"20","author":"ER Ebel","year":"2021","unstructured":"Ebel ER, Reis F, Petrov DA, Beleza S. Historical trends and new surveillance of Plasmodium falciparum drug resistance markers in Angola. Malar J. 2021;20(1):175.","journal-title":"Malar J"},{"issue":"1","key":"5939_CR57","first-page":"1","volume":"14","author":"V Foumane Ngane","year":"2015","unstructured":"Foumane Ngane V, Allico Djaman J, Culeux C, Piette N, Carnevale P, Besnard P, et al. Molecular epidemiology of drug-resistant Plasmodium falciparum in Benguela province. Angola Malar J. 2015;14(1):1\u20136.","journal-title":"Angola Malar J"},{"key":"5939_CR58","doi-asserted-by":"crossref","unstructured":"Fan\u00e7ony C, Gamboa D, Sebasti\u00e3o Y, Hallett R, Sutherland C, Sousa-Figueiredo JC, Nery SV. Various pfcrt and pfmdr1 genotypes of Plasmodium falciparum cocirculate with P. malariae, P. ovale spp., and P. vivax in northern Angola. Antimicrobial agents and chemotherapy. 2012 Oct;56(10):5271-7.","DOI":"10.1128\/AAC.00559-12"},{"key":"5939_CR59","doi-asserted-by":"crossref","unstructured":"Gama BE, Pereira-Carvalho GA, Lutucuta Kosi FJ, Almeida de Oliveira NK, Fortes F, Rosenthal PJ, Daniel-Ribeiro CT, de F\u00e1tima Ferreira-da-Cruz M. Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene. Malaria Journal. 2010 Jun 18;9(1):174.","DOI":"10.1186\/1475-2875-9-174"},{"issue":"10","key":"5939_CR60","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/j.1365-3156.2009.02369.x","volume":"14","author":"M Menegon","year":"2009","unstructured":"Menegon M, Pearce RJ, Inojosa WO, Pisani V, Abel PM, Matondo A, et al. Monitoring for multidrug-resistant Plasmodium falciparum isolates and analysis of pyrimethamine resistance evolution in Uige province. Angola Trop Med Int Heal. 2009;14(10):1251\u20137.","journal-title":"Angola Trop Med Int Heal"},{"key":"5939_CR61","first-page":"1","volume":"7","author":"P Figueiredo","year":"2008","unstructured":"Figueiredo P, Benchimol C, Lopes D, Bernardino L, Do Ros\u00e1rio VE, Varandas L, et al. Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda. Angola Malar J. 2008;7:1\u20137.","journal-title":"Angola Malar J"},{"issue":"12","key":"5939_CR62","doi-asserted-by":"publisher","first-page":"e983","DOI":"10.1016\/S2666-5247(23)00211-2","volume":"4","author":"E Gu\u00e9mas","year":"2023","unstructured":"Gu\u00e9mas E, Copp\u00e9e R, M\u00e9nard S, du Manoir M, Nsango S, Makaba Mvumbi D, et al. Evolution and spread of Plasmodium falciparum mutations associated with resistance to sulfadoxine\u2013pyrimethamine in central Africa: a cross-sectional study. The Lancet Microbe. 2023;4(12):e983\u201393.","journal-title":"The Lancet Microbe"},{"issue":"1","key":"5939_CR63","first-page":"1","volume":"15","author":"EPS Kaingona-Daniel","year":"2016","unstructured":"Kaingona-Daniel EPS, Gomes LR, Gama BE, Almeida-De-Oliveira NK, Fortes F, M\u00e9nard D, et al. Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango. Angola Malar J. 2016;15(1):1\u20136.","journal-title":"Angola Malar J"},{"key":"5939_CR64","doi-asserted-by":"crossref","unstructured":"Gama BE, Pereira-Carvalho GA, Lutucuta Kosi FJ, Almeida de Oliveira NK, Fortes F, Rosenthal PJ, do Ros\u00e1rio VE, Daniel-Ribeiro CT, F\u00e1tima Ferreira-da-Cruz MD. Molecular markers of antifolate resistance in Plasmodium falciparum isolates from Luanda, Angola. Malaria Journal. 2011 Aug 24;10(1):248.","DOI":"10.1186\/1475-2875-10-248"},{"issue":"4","key":"5939_CR65","first-page":"235","volume":"16","author":"L Pinheiro","year":"2003","unstructured":"Pinheiro L, Ros\u00e1rio VE. Resist\u00eancia \u00e0 pirimetamina e ao cicloguanil na \u00c1frica Ocidental - Presen\u00e7a da muta\u00e7\u00e3o 59 Arg no gene dhfr do Plasmodium falciparum. Acta Med Port. 2003;16(4):235\u20138.","journal-title":"Acta Med Port"},{"issue":"5","key":"5939_CR66","first-page":"1","volume":"11","author":"ABB Rodrigues","year":"2022","unstructured":"Rodrigues ABB, de Abreu-Fernandes R, Neto Z, Jandondo D, Almeida-De-oliveira NK, de Lavigne Mello AR, et al. Pfkelch13 Plasmodium falciparum Mutations in Huambo. Angola Pathogens. 2022;11(5):1\u20137.","journal-title":"Angola Pathogens"},{"issue":"1","key":"5939_CR67","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12936-018-2233-5","volume":"17","author":"D Ljolje","year":"2018","unstructured":"Ljolje D, Dimbu PR, Kelley J, Goldman I, Nace D, Macaia A, et al. Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015. Malar J. 2018;17(1):84.","journal-title":"Malar J"},{"issue":"1","key":"5939_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-015-1018-3","volume":"14","author":"K Kiaco","year":"2015","unstructured":"Kiaco K, Teixeira J, Machado M, Do Ros\u00e1rio V, Lopes D. Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola. Malar J. 2015;14(1):1\u201310.","journal-title":"Malar J"},{"issue":"3","key":"5939_CR69","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1371\/journal.pone.0119215","volume":"10","author":"C Escobar","year":"2015","unstructured":"Escobar C, Pateira S, Lobo E, Lobo L, Teodosio R, Dias F, et al. Polymorphisms in Plasmodium falciparum K13-propeller in Angola and Mozambique after the introduction of the ACTs. PLoS ONE. 2015;10(3):2\u20137.","journal-title":"PLoS ONE"},{"issue":"4","key":"5939_CR70","doi-asserted-by":"publisher","first-page":"e01601","DOI":"10.1128\/aac.01601-22","volume":"67","author":"SR Rosillo","year":"2023","unstructured":"Rosillo SR, Dimbu PR, C\u00e2ndido AL, Oh JH, Ferreira CM, Nieto Andrade B, et al. Molecular markers of sulfadoxine-pyrimethamine resistance in samples from children with uncomplicated Plasmodium falciparum at three sites in angola in 2019. Antimicro Agent Chemother. 2023;67(4):e01601-e1622.","journal-title":"Antimicro Agent Chemother."},{"issue":"1","key":"5939_CR71","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12936-024-05240-2","volume":"24","author":"D Duarte","year":"2025","unstructured":"Duarte D, Manuel F, Dias A, Sacato E, Taleingue E, Daniel E, et al. Low prevalence of copy number variation in pfmdr1 and pfpm2 in Plasmodium falciparum isolates from southern Angola. Malar J. 2025;24(1):5.","journal-title":"Malar J"},{"issue":"1","key":"5939_CR72","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1186\/1475-2875-12-459","volume":"12","author":"DM Mvumbi","year":"2013","unstructured":"Mvumbi DM, Boreux R, Sacheli R, Lelo M, Lengu B, Nani-Tuma S, et al. Assessment of pfcrt 72\u201376 haplotypes eight years after chloroquine withdrawal in Kinshasa, Democratic Republic of Congo. Malar J. 2013;12(1):459.","journal-title":"Malar J"},{"issue":"1","key":"5939_CR73","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1475-2875-13-120","volume":"13","author":"L Golassa","year":"2014","unstructured":"Golassa L, Enweji N, Erko B, Aseffa A, Swedberg G. High prevalence of pfcrt-CVIET haplotype in isolates from asymptomatic and symptomatic patients in south-central Oromia, Ethiopia. Malar J. 2014;13(1):120.","journal-title":"Malar J"},{"issue":"1","key":"5939_CR74","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/1475-2875-10-304","volume":"10","author":"M Frank","year":"2011","unstructured":"Frank M, Lehners N, Mayengue PI, Gabor J, Dal-Bianco M, Kombila DU, et al. A thirteen-year analysis of Plasmodium falciparum populations reveals high conservation of the mutant pfcrt haplotype despite the withdrawal of chloroquine from national treatment guidelines in Gabon. Malar J. 2011;10(1):304.","journal-title":"Malar J"},{"issue":"1","key":"5939_CR75","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12936-021-03636-y","volume":"20","author":"DM Yobi","year":"2021","unstructured":"Yobi DM, Kayiba NK, Mvumbi DM, Boreux R, Kabututu PZ, Situakibanza HN, et al. Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfk13-propeller, pfcrt and pfmdr1 genes in isolates from treatment failure patients in democratic republic of congo, 2018\u20132019. Malar J. 2021;20(1):144.","journal-title":"Malar J"},{"key":"5939_CR76","doi-asserted-by":"crossref","unstructured":"Kayiba Kalenda N, Tshibangu-Kabamba E, Rosas-Aguirre A, Kaku N, Nakagama Y, Kaneko A, Makaba DM, Malekita DY, Devleesschauwer B, Likwela JL, Zakayi PK. The landscape of drug resistance in Plasmodium falciparum malaria in the Democratic Republic of Congo: a mapping systematic review. Tropical Medicine and Health. 2023;51(1).","DOI":"10.1186\/s41182-023-00551-7"},{"issue":"14","key":"5939_CR77","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jgar.2018.08.003","volume":"1","author":"DF Voumbo-Matoumona","year":"2018","unstructured":"Voumbo-Matoumona DF, Akiana J, Madamet M, Kouna LC, Lekana-Douki JB, Pradines B. High prevalence of Plasmodium falciparum antimalarial drug resistance markers in isolates from asymptomatic patients from the Republic of the Congo between 2010 and 2015. J Glo Antimicro Res. 2018;1(14):277\u201383.","journal-title":"J Glo Antimicro Res."},{"issue":"12","key":"5939_CR78","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1086\/504269","volume":"193","author":"M Alifrangis","year":"2006","unstructured":"Alifrangis M, Dalgaard MB, Lusingu JP, Vestergaard LS, Staalsoe T, Jensen AT, et al. Occurrence of the southeast Asian\/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania. J Infect Dis. 2006;193(12):1738\u201341.","journal-title":"J Infect Dis"},{"issue":"2","key":"5939_CR79","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4269\/ajtmh.19-0749","volume":"102","author":"NW Lucchi","year":"2019","unstructured":"Lucchi NW, Abdallah R, Louzada J, Udhayakumar V, Oliveira-Ferreira J. Molecular surveillance for polymorphisms associated with artemisinin-based combination therapy resistance in Plasmodium falciparum isolates collected in the State of Roraima, Brazil. American J Tropical Med Hyg. 2019;102(2):310.","journal-title":"American J Tropical Med Hyg."},{"issue":"26","key":"5939_CR80","volume":"1","author":"JC Djontu","year":"2024","unstructured":"Djontu JC, Baina MT, Ntabi JD, Lissom A, Umuhoza DM, Vouvoungui CJ, et al. Profile of molecular markers of Sulfadoxine-Pyrimethamine-resistant Plasmodium falciparum in individuals living in southern area of Brazzaville, Republic of Congo. Int J Parasit: Drugs Drug Res. 2024;1(26):100569.","journal-title":"Int J Parasit: Drugs Drug Res."},{"key":"5939_CR81","doi-asserted-by":"crossref","unstructured":"Kanyamukenge DB, Maseko T, Khote FL, Makenga G, Mavoko HM, Tevuzula VM, Mulangu AM, Sompwe EM, Rietveld H, Manyando C, Van Geertruyden JP. Young children with severe malaria in the Kapolowe health zone: an analysis of their parents\u2019 health-seeking behaviors and the challenges they face. Malaria Journal. 2026 Feb 12.","DOI":"10.1186\/s12936-026-05819-x"},{"issue":"1","key":"5939_CR82","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12936-016-1659-x","volume":"16","author":"G Mpanya","year":"2017","unstructured":"Mpanya G, Tshefu A, Likwela JL. The malaria testing and treatment market in Kinshasa, democratic republic of the Congo, 2013. Malar J. 2017;16(1):94.","journal-title":"Malar J"},{"issue":"4","key":"5939_CR83","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.medmal.2018.02.003","volume":"48","author":"PN Mandoko","year":"2018","unstructured":"Mandoko PN, Sinou V, Mbongi DM, Mumba DN, Mesia GK, Likwela JL, et al. Access to artemisinin-based combination therapies and other anti-malarial drugs in Kinshasa. Med Mal Infect. 2018;48(4):269\u201377.","journal-title":"Med Mal Infect"},{"issue":"10","key":"5939_CR84","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1093\/jac\/dky258","volume":"73","author":"P Nkoli Mandoko","year":"2018","unstructured":"Nkoli Mandoko P, Rouvier F, Matendo Kakina L, Moke Mbongi D, Latour C, Losimba Likwela J, et al. Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine\/pyrimethamine in the Democratic Republic of the Congo: emergence of highly resistant pfdhfr\/pfdhps alleles. J Antimicro Chemother. 2018;73(10):2704\u201315.","journal-title":"J Antimicro Chemother."},{"key":"5939_CR85","first-page":"2017","volume-title":"WHO Evidence Review Group on Intermittent Preventive Treatment (IPT) of malaria in pregnancy","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. WHO Evidence Review Group on Intermittent Preventive Treatment (IPT) of malaria in pregnancy. Geneva, Switzerland: World Health Organization; 2013. p. 2017\u2013106."},{"issue":"1","key":"5939_CR86","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s12936-015-0977-8","volume":"14","author":"V Baraka","year":"2015","unstructured":"Baraka V, Ishengoma DS, Fransis F, Minja DT, Madebe RA, Ngatunga D, et al. High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania. Malar J. 2015;14(1):439.","journal-title":"Malar J"},{"issue":"13","key":"5939_CR87","doi-asserted-by":"publisher","first-page":"1059695","DOI":"10.3389\/fmicb.2022.1059695","volume":"2","author":"TA Leski","year":"2022","unstructured":"Leski TA, Taitt CR, Colston SM, Bangura U, Holtz A, Yasuda CY, et al. Prevalence of malaria resistance-associated mutations in Plasmodium falciparum circulating in 2017\u20132018, Bo, Sierra Leone. Frontiers Microbio. 2022;2(13):1059695.","journal-title":"Frontiers Microbio."},{"issue":"1","key":"5939_CR88","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12936-023-04589-0","volume":"22","author":"C da Silva","year":"2023","unstructured":"da Silva C, Matias D, Dias B, Cancio B, Silva M, Viegas R, et al. Anti-malarial resistance in Mozambique: Absence of Plasmodium falciparum Kelch 13 (K13) propeller domain polymorphisms associated with resistance to artemisinins. Malar J. 2023;22(1):160.","journal-title":"Malar J"},{"issue":"2","key":"5939_CR89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264548","volume":"17","author":"FV Ajogbasile","year":"2022","unstructured":"Ajogbasile FV, Oluniyi PE, Kayode AT, Akano KO, Adegboyega BB, Philip C, et al. Molecular profiling of the artemisinin resistance Kelch 13 gene in Plasmodium falciparum from Nigeria. PLoS ONE. 2022;17(2):e0264548.","journal-title":"PLoS ONE"},{"issue":"6","key":"5939_CR90","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.4269\/ajtmh.14-0605","volume":"92","author":"A Ouattara","year":"2015","unstructured":"Ouattara A, Kone A, Adams M, Fofana B, Maiga AW, Hampton S, et al. Polymorphisms in the K13-Propeller Gene in Artemisinin-Susceptible Plasmodium falciparum Parasites from Bougoula-Hameau and Bandiagara, Mali. American J Tropical Med Hyg. 2015;92(6):1202.","journal-title":"American J Tropical Med Hyg."},{"issue":"1","key":"5939_CR91","first-page":"27988","volume":"14","author":"MT Baina","year":"2024","unstructured":"Baina MT, Djontu JC, Mbama Ntabi JD, Mfoutou Mapanguy CC, Lissom A, Vouvoungui CJ, et al. Polymorphisms in the Pfcrt, Pfmdr1, and Pfk13 genes of Plasmodium falciparum isolates from southern Brazzaville. Rep Congo Sci Rep. 2024;14(1):27988.","journal-title":"Rep Congo Sci Rep."},{"issue":"2","key":"5939_CR92","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1128\/AAC.00950-12","volume":"57","author":"G Fr\u00f6berg","year":"2013","unstructured":"Fr\u00f6berg G, Ferreira PE, M\u00e5rtensson A, Ali A, Bj\u00f6rkman A, Gil JP. Assessing the Cost-Benefit Effect of a Plasmodium falciparum Drug Resistance Mutation on Parasite Growth In Vitro. Antimicrobial Agent Chemother. 2013;57(2):887\u201392.","journal-title":"Antimicrobial Agent Chemother."},{"issue":"3","key":"5939_CR93","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1128\/AAC.00875-06","volume":"51","author":"GS Humphreys","year":"2007","unstructured":"Humphreys GS, Merinopoulos I, Ahmed J, Whitty CJ, Mutabingwa TK, Sutherland CJ, et al. Amodiaquine and Artemether-Lumefantrine Select Distinct Alleles of the Plasmodium falciparum mdr1 Gene in Tanzanian Children Treated for Uncomplicated Malaria. Antimicro Agent Chemother. 2007;51(3):991\u20137.","journal-title":"Antimicro Agent Chemother."},{"issue":"1","key":"5939_CR94","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12936-021-03823-x","volume":"20","author":"M Duvalsaint","year":"2021","unstructured":"Duvalsaint M, Conrad MD, Tukwasibwe S, Tumwebaze PK, Legac J, Cooper RA, et al. Balanced impacts of fitness and drug pressure on the evolution of PfMDR1 polymorphisms in Plasmodium falciparum. Malar J. 2021;20(1):292.","journal-title":"Malar J"},{"key":"5939_CR95","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00220-21","author":"C Rasmussen","year":"2021","unstructured":"Rasmussen C, Ringwald P. Continued low efficacy of Artemether-Lumefantrine in Angola? Antimicrob Agents Chemother. 2021. https:\/\/doi.org\/10.1128\/AAC.00220-21.","journal-title":"Antimicrob Agents Chemother"},{"key":"5939_CR96","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00338-21","author":"PR Dimbu","year":"2021","unstructured":"Dimbu PR, Horth R, C\u00e2ndido ALM, Ferreira CM, Caquece F, Garcia LEA, et al. Reply to Rasmussen and Ringwald, \u201cContinued low efficacy of Artemether-Lumefantrine in Angola?\u201d Antimicrob Agents Chemother. 2021. https:\/\/doi.org\/10.1128\/AAC.00338-21.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"5939_CR97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179142","volume":"12","author":"DM Mvumbi","year":"2017","unstructured":"Mvumbi DM, Bobanga TL, Kayembe JMN, Mvumbi GL, Situakibanza HNT, Benoit-Vical F, et al. Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo. PLoS ONE. 2017;12(6):e0179142. https:\/\/doi.org\/10.1371\/journal.pone.0179142.","journal-title":"PLoS ONE"},{"issue":"10","key":"5939_CR98","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1086\/497337","volume":"192","author":"A Uhlemann","year":"2005","unstructured":"Uhlemann A, Ramharter M, Lell B, Kremsner PG, Krishna S. Amplification of Plasmodium falciparum Multidrug Resistance Gene 1 in isolates from Gabon. J Infect Dis. 2005;192(10):1830\u20135. https:\/\/doi.org\/10.1086\/497337.","journal-title":"J Infect Dis"},{"issue":"1","key":"5939_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-017-1868-y","volume":"16","author":"CN Nguetse","year":"2017","unstructured":"Nguetse CN, Adegnika AA, Agbenyega T, Ogutu BR, Krishna S, Kremsner PG, et al. Molecular markers of anti-malarial drug resistance in Central, West and East African children with severe malaria. Malar J. 2017;16(1):217. https:\/\/doi.org\/10.1186\/s12936-017-1868-y.","journal-title":"Malar J"},{"issue":"1","key":"5939_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/srep08308","volume":"5","author":"BS Ngalah","year":"2015","unstructured":"Ngalah BS, Ingasia LA, Cheruiyot AC, Chebon LJ, Juma DW, Muiruri P, et al. Analysis of major genome loci underlying Artemisinin resistance and pfmdr1 copy number in pre- and post-ACTs in Western Kenya. Sci Rep. 2015;5(1):8308. https:\/\/doi.org\/10.1038\/srep08308.","journal-title":"Sci Rep"},{"issue":"1","key":"5939_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02652-2","volume":"20","author":"DM Wakoli","year":"2022","unstructured":"Wakoli DM, Ondigo BN, Ochora DO, Amwoma JG, Okore W, Mwakio EW, et al. Impact of parasite genomic dynamics on the sensitivity of Plasmodium falciparum isolates to piperaquine and other antimalarial drugs. BMC Med. 2022;20(1):448. https:\/\/doi.org\/10.1186\/s12916-022-02652-2.","journal-title":"BMC Med"},{"issue":"11","key":"5939_CR102","doi-asserted-by":"publisher","first-page":"5408","DOI":"10.1128\/AAC.05102-11","volume":"55","author":"NB Gadalla","year":"2011","unstructured":"Gadalla NB, Adam I, Elzaki SE, Bashir S, Mukhtar I, Oguike M, et al. Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with Artemether-Lumefantrine. Antimicrob Agents Chemother. 2011;55(11):5408\u201311. https:\/\/doi.org\/10.1128\/AAC.05102-11.","journal-title":"Antimicrob Agents Chemother"},{"key":"5939_CR103","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01818-18","author":"V Asua","year":"2019","unstructured":"Asua V, Vinden J, Conrad MD, Legac J, Kigozi SP, Kamya MR, et al. Changing molecular markers of antimalarial drug sensitivity across Uganda. Antimicrob Agents Chemother. 2019. https:\/\/doi.org\/10.1128\/AAC.01818-18.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"5939_CR104","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1475-2875-8-11","volume":"8","author":"P Lim","year":"2009","unstructured":"Lim P, Alker AP, Khim N, Shah NK, Incardona S, Doung S, et al. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Malar J. 2009;8(1):11.","journal-title":"Malar J"},{"issue":"1","key":"5939_CR105","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12936-019-2756-4","volume":"18","author":"D Leroy","year":"2019","unstructured":"Leroy D, Macintyre F, Adoke Y, Ouoba S, Barry A, Mombo-Ngoma G, et al. African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker. Malar J. 2019;18(1):126.","journal-title":"Malar J"},{"issue":"7","key":"5939_CR106","doi-asserted-by":"publisher","first-page":"e00346","DOI":"10.1128\/aac.00346-24","volume":"68","author":"N Brown","year":"2024","unstructured":"Brown N, da Silva C, Webb C, Matias D, Dias B, Cancio B, et al. Antimalarial resistance risk in Mozambique detected by a novel quadruplex droplet digital PCR assay. Antimicro Agent Chemother. 2024;68(7):e00346-e424.","journal-title":"Antimicro Agent Chemother."},{"issue":"1","key":"5939_CR107","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3201\/eid2401.170864","volume":"24","author":"H Gupta","year":"2018","unstructured":"Gupta H, Macete E, Bulo H, Salvador C, Warsame M, Carvalho E, et al. Drug-resistant polymorphisms and copy numbers in Plasmodium falciparum, Mozambique, 2015. Emerg Infect Dis. 2018;24(1):40.","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"5939_CR108","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240174","volume":"15","author":"H Gupta","year":"2020","unstructured":"Gupta H, Galatas B, Chidimatembue A, Huijben S, Cister\u00f3 P, Matambisso G, et al. Effect of mass dihydroartemisinin\u2013piperaquine administration in southern Mozambique on the carriage of molecular markers of antimalarial resistance. PLoS ONE. 2020;15(10):e0240174.","journal-title":"PLoS ONE"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-026-05939-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-05939-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-05939-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:03:22Z","timestamp":1783987402000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12936-026-05939-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5939"],"URL":"https:\/\/doi.org\/10.1186\/s12936-026-05939-4","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"262"}}